Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Singapore, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Republic Power Group Limited (Nasdaq: RPGL) (the “Company” or “Republic Power”), a provider of customized enterprise resource planning software...
-
Nassau, The Bahamas, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation is thrilled to announce the destination welcomed a record-breaking 11.22 million...
-
Taipei, Taiwan, May 15, 2024 (GLOBE NEWSWIRE) -- Semilux International Ltd. (“Semilux” or the “Company”) (NASDAQ: SELX), today announced that it filed its annual report on Form 20-F (the “Form...
-
Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd. (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon...
-
BEIJING, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a leading provider of advanced mobile internet infrastructure and platform...
-
New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”)...
-
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY,...
-
Victoria, BC, Canada, July 21, 2022 (GLOBE NEWSWIRE) -- Highlights for fiscal year ending March 31, 2022: One-year annual return of 7.4%, representing $4.4 billion in added value Five-year...
-
Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, meddelar idag att årsredovisningen för 2021 nu...
-
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for...